CervoMed (CRVO) Misses Q3 EPS by 55c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts CRVO Hot Sheet
Join SI Premium – FREE
CervoMed (NASDAQ: CRVO) reported Q3 EPS of ($0.55). Revenue for the quarter came in at $1.94 million.
For earnings history and earnings-related data on CervoMed (CRVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle, Broadcom and SpaceX seek debt deals to pay for AI chips - WSJ
- Jefferies Upgrades Arena REIT (ARF:AU) to Buy
- Netweb Technologies India (NETWEB:IN) PT Raised to INR5,250 at BofA Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
